We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRNS icon
251
Varonis Systems
VRNS
$5.13B
$11.7M 0.05%
192,631
+23,480
+14% +$1.47M
CI icon
252
Cigna
CI
$79.6B
$11.7M 0.05%
58,311
+5,145
+10% +$1.12M
XEL icon
253
Xcel Energy
XEL
$50.1B
$11.7M 0.05%
186,701
+16,440
+10% +$1.11M
ROST icon
254
Ross Stores
ROST
$80.5B
$11.6M 0.05%
106,584
+9,405
+10% +$1.13M
SPG icon
255
Simon Property Group
SPG
$76.8B
$11.6M 0.05%
89,066
+7,747
+10% +$1.01M
PSA icon
256
Public Storage
PSA
$61.7B
$11.5M 0.05%
38,742
+3,418
+10% +$1.07M
FBIN icon
257
Fortune Brands Innovations
FBIN
$6.09B
$11.5M 0.05%
150,522
+13,282
+10% +$1.1M
GIS icon
258
General Mills
GIS
$20.1B
$11.4M 0.05%
191,291
+16,880
+10% +$997K
DOW icon
259
Dow Inc
DOW
$20.8B
$11.4M 0.05%
197,786
+17,452
+10% +$1.07M
WELL icon
260
Welltower
WELL
$175B
$11.4M 0.05%
137,967
+12,014
+10% +$1.03M
DG icon
261
Dollar General
DG
$27.8B
$11.4M 0.05%
53,539
+4,724
+10% +$1.07M
ARE icon
262
Alexandria Real Estate Equities
ARE
$9.41B
$11.3M 0.05%
59,015
+5,208
+10% +$1.04M
CTSH icon
263
Cognizant
CTSH
$23.8B
$11.3M 0.05%
151,789
+13,394
+10% +$988K
D icon
264
Dominion Energy
D
$62.1B
$11.2M 0.05%
154,006
+13,365
+10% +$1.02M
GLBE icon
265
Global E Online
GLBE
$6.53B
$11.2M 0.05%
+155,334
New +$10.5M
NSC icon
266
Norfolk Southern
NSC
$76.1B
$11.1M 0.05%
46,560
+4,108
+10% +$1.05M
TXNM
267
TXNM Energy Inc
TXNM
$6.43B
$11.1M 0.05%
224,000
+62,000
+38% +$3.03M
ARKK icon
268
PUT
ARK Innovation ETF
ARKK
$5.74B
$11.1M 0.05%
+100,000
New +$12M
ATVI
269
DELISTED
Activision Blizzard
ATVI
$11M 0.05%
142,320
+12,558
+10% +$1.05M
KRE icon
270
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
$10.8M 0.05%
+160,000
New +$10.3M
MCK icon
271
McKesson
MCK
$104B
$10.8M 0.05%
54,328
+4,794
+10% +$958K
WBA
272
DELISTED
Walgreens Boots Alliance
WBA
$10.8M 0.05%
230,103
+15,657
+7% +$755K
AER icon
273
AerCap
AER
$24.3B
$10.8M 0.05%
186,900
MET icon
274
MetLife
MET
$62.7B
$10.8M 0.05%
174,752
+15,420
+10% +$928K
SPT icon
275
Sprout Social
SPT
$522M
$10.8M 0.05%
88,345
-43,640
-33% -$4.74M

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.